Determination method of five components in Toujiequwen preparation and its application

The content of forsythia glycoside in the permeable vermicelli is determined by one-test and multiple evaluation method, and the relative correction factor is used to calculate other components, which solves the problem of difficulty in determining the content of multiple components in the prior art, achieving efficient and accurate quality control and scientific research needs.

CN118671242BActive Publication Date: 2024-11-12GUANGZHOU BAIYUSN HUTCHISON WHAMPOA CHINESE MEDICINE
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411168867.8
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-08-23
Publication Date
2024-11-12
Estimated Expiration
2044-08-23

AI Technical Summary

Technical Problem

The prior art is difficult to accurately determine the content of multiple components in the permeable vermicelli blemish preparation at the same time, and the current quality control methods are cumbersome, time-consuming and costly, and cannot meet the needs of research on the basis of drug-effective substances and mechanism of action.

Method used

By using one-test and multiple evaluation method, the content of forsythia glycoside was determined, and the relative correction factor was used to calculate forsythia glycoside I, forsythia glycoside A, (+)-rosinin-β-D-glucopyranoside and forsythia glycoside The content of lipotin simplifies the detection process and improves the detection efficiency and accuracy.

Benefits of technology

The accurate determination of the five ingredients in the permeable vermicelli preparation has been achieved, the quality control level has been improved, the cost has been saved, and the needs of scientific research is met. The method is highly practical, stable and controllable.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118671242B_ABST
    Figure CN118671242B_ABST
Patent Text Reader

Abstract

The present invention discloses a method for determining the contents of five components in a Toujie Quwen preparation and its application, wherein the method comprises the following steps: firstly subjecting a test solution of the Toujie Quwen preparation to be tested to HPLC detection to obtain the content of forsythin; and then determining the content of five components in a Toujie Quwen preparation according to the formula (C i / W)×(A r / A i )×V×D×F i / r , calculate the contents of forsythiaside I, forsythiaside A, (+) pinoresinol-β-D-pyranoglucoside and forsythiaside in the tested Toujie Quwen preparation. The present invention establishes a method for determining the contents of multiple components of Toujie Quwen preparation by a one-test-multiple-evaluation method, which greatly improves the quality control level of Toujie Quwen preparation, and also meets the needs of relevant scientific connotation research. The method of the present invention is highly practical, cost-saving, stable and controllable.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the technical field of traditional Chinese medicine detection, and more specifically, the present invention relates to a method for determining the contents of five components in Toujie Quwen granules by a one-test-multiple-evaluation method and its application. Background Art

[0002] The Toujie Quwen preparation is mainly composed of 16 Chinese medicinal herbs including Forsythia suspensa, Trillium gracile, Honeysuckle, Scutellaria baicalensis, Folium Isatidis, Astragalus, Radix Pseudostellariae, Poria, Radix Bupleuri, Artemisia annua, Periostracum Cicadae, Peucedanum chinense, Fritillaria thunbergii, Scrophularia ningpoensis and Prunus mume, including but not limited to Chinese medicinal compound preparations in pharmaceutically acceptable dosage forms such as granules, oral liquids and decoctions. The preparation has the effects of clearing away heat and detoxifying, dispersing wind and clearing the surface, relieving cough and reducing phlegm, and replenishing qi and nourishing yin, and can be used to treat diseases such as viral pneumonia.

[0003] The Toujiequwen preparation is composed of a variety of medicinal materials with complex chemical composition. Its pharmacodynamic material basis and mechanism of action are not yet fully understood. Among them, the recipe uses a lot of Forsythia suspensa, which is light and cold, moistens the lungs, and clears lung heat. Modern pharmacological studies have also shown that the forsythiaside and forsythiaside A contained in Forsythia suspensa have antiviral and anti-inflammatory effects. Therefore, multiple components in Forsythia suspensa may be the potential pharmacodynamic material basis of Toujiequwen granules. However, there are few studies on the quality control of Toujiequwen preparations. The current quality control methods for hospital preparations mainly include the use of two HPLC methods to detect the content of forsythiaside, a single component in Forsythia suspensa, and baicalin, a single component in Scutellaria baicalensis. The methods are cumbersome, time-consuming, and costly, and they cannot control the content of multiple quality control indicators at the same time. They cannot fully reflect the quality of Toujiequwen preparations, nor can they meet the needs of research on the pharmacodynamic material basis and mechanism of action of Toujiequwen preparations.

[0004] The one-test-multiple-evaluation method is a quality control method that measures the content of a representative component (stable, cheap, and easily available) and calculates the content of multiple other components to be measured at the same time, so that the calculated value and the actual value meet the requirements of quantitative methodology. It can better solve the bottleneck problem of lack of reference materials in the quality control of traditional Chinese medicine, and can better complete the quantitative determination of unstable components. It has the advantages of low detection cost and high analysis efficiency. However, the development of the one-test-multiple-evaluation method also has many technical difficulties such as the selection of internal standard substances, the selection of other components to be measured, the exploration of liquid phase methods, the calculation of relative correction factors and stability; and the raw materials of the Toujie Quwen preparation are many and the chemical composition is complex. It is difficult to separate the multiple components of the Toujie Quwen preparation using high performance liquid chromatography; in addition, when the high performance liquid chromatography is used for content determination, the requirements for liquid phase conditions are very high, and slight adjustments to the liquid phase conditions may significantly affect the reliability of the test results; therefore, there is no report or application of the one-test-multiple-evaluation technology to determine the content of multiple components of the Toujie Quwen preparation.

[0005] In summary, it is necessary to conduct in-depth research on the content determination of multiple components in the toujiequbing preparation. Summary of the invention

[0006] Based on this, the object of the present invention is to provide a method for determining the contents of five components in a Toujie Quwen preparation and its application. By using the determination method of the present invention, the contents of forsythiaside I, forsythiaside A, (+) pinoresinol-β-D-pyranoglucoside and forsythiaside in the Toujie Quwen preparation can be calculated by only determining the content of forsythiaside.

[0007] The technical solutions for achieving the above-mentioned invention objectives include the following.

[0008] The first aspect of the present invention provides a method for determining the contents of five components in a tolujiequwen preparation, wherein the five components are forsythiaside, forsythiaside I, forsythiaside A, (+) pinoresinol-β-D-pyranoglucoside and forsythiaside, comprising the following steps:

[0009] (1) Using 50% to 70% methanol as the extraction solvent, ultrasonically extract the test permeable and anti-plaque preparation, filter, and take the filtrate to obtain the test sample solution;

[0010] (2) HPLC detection was performed on the forsythiaside reference solution with a series of concentrations and the test solution of step (1) to obtain a chromatogram; in the HPLC detection, the mobile phase A was acetonitrile, the mobile phase B was 0.1%~1% phosphoric acid aqueous solution, and the gradient elution program was: 0min→30min, 14%~15%A; 30min→31min, 14%~15%→23%~24%A, 31min→50min, 23%~24%A; 50min→65min, 23%~24%→60%A;

[0011] (3) calculating the content of forsythiaside in the to-be-tested tolujiequwen preparation according to the peak area of ​​forsythiaside in the chromatogram of step (2);

[0012] (4) According to the formula (C i / W)×(A r / A i )×V×D×F i / r , calculate the contents of forsythiaside I, forsythiaside A, (+) pinoresinol-β-D-pyranoglucoside and forsythiaside in the tested toluene-resolving and anti-epidemic preparation; where C i is the concentration of forsythin in the tested peony root preparation, W is the sampling amount of the tested peony root preparation, A r is the peak area of ​​forsythiaside I, forsythiaside A, (+) pinoresinol-β-D-pyranoglucopyranoside, or forsythiaside. i is the peak area of ​​forsythiaside, V is the volume of the extraction solvent, D is the dilution factor, Fi / r is the relative correction factor of forsythiaside I, forsythiaside A, (+) pinoresinol-β-D-pyranoglucoside, or forsythiaside; the relative correction factors of forsythiaside I, forsythiaside A, (+) pinoresinol-β-D-pyranoglucoside, or forsythiaside are 2.21±0.30, 2.21±0.30, 1.20±0.30, and 0.71±0.30, respectively.

[0013] The second aspect of the present invention provides the application of the method for determining the contents of the five components in the above-mentioned Toujie Qubing preparation in the quality control of the Toujie Qubing preparation.

[0014] The present invention establishes a method for determining the content of multiple components of a Toujie Quwen preparation by one-test and multiple-evaluation, which uses forsythiaside as an internal standard, develops an HPLC content determination method, and establishes a stable relative correction factor between forsythiaside and forsythiaside I, forsythiaside A, (+) pinoresinol-β-D-pyranoglucoside, and forsythiaside, so that by only determining the content of forsythiaside, the relative correction factor can be used to simultaneously and reliably calculate the content of forsythiaside I, forsythiaside A, (+) pinoresinol-β-D-pyranoglucoside, and forsythiaside in the Toujie Quwen preparation, which greatly improves the quality control level of the Toujie Quwen preparation and meets the needs of related scientific research. The method of the present invention is highly practical, cost-saving, stable and controllable. BRIEF DESCRIPTION OF THE DRAWINGS

[0015] Figure 1 This is an HPLC chart of the Toujie Quwen granules in Example 1 of the present invention; in the chart, 1. Forsythiaside I; 2. Forsythiaside A; 3. (+) pinoresin-β-D-pyranoglucoside; 4. Forsythiaside; 5. Forsythiaside.

[0016] Figure 2 This is an HPLC chart of the reference substance mixed solution I in Example 2 of the present invention; in the chart, 1, forsythiaside I; 2, forsythiaside A; 3, (+) pinoresinol-β-D-pyranoglucoside; 4, forsythiaside; 5, forsythiaside.

[0017] Figure 3 This is an HPLC chart of the Toujie Quwen granules in Comparative Example 1 of the present invention; in the chart, 1. Forsythiaside I; 2. Forsythiaside A; 3. (+) pinoresin-β-D-pyranoglucoside; 4. Forsythiaside; 5. Forsythiaside.

[0018] Figure 4 This is an HPLC chart of the Toujie Quwen granules in Comparative Example 2 of the present invention; in the chart, 1. Forsythiaside I; 2. Forsythiaside A; 3. (+) pinoresinol-β-D-pyranoglucoside; 4. Forsythiaside; 5. Forsythiaside.

[0019] Figure 5This is an HPLC chart of the Toujie Quwen granules in Comparative Example 3 of the present invention; in the chart, 1. Forsythiaside I; 2. Forsythiaside A; 3. (+) pinoresin-β-D-pyranoglucoside; 4. Forsythiaside.

[0020] Figure 6 This is an HPLC chart of the Toujie Quwen granules in Comparative Example 4 of the present invention; in the chart, 1. Forsythiaside I; 2. Forsythiaside A; 3. (+) pinoresinol-β-D-pyranoglucoside; 4. Forsythiaside; 5. Forsythiaside.

[0021] Figure 7 This is an HPLC chart of the Toujie Quwen granules in Comparative Example 5 of the present invention; in the chart, 1. Forsythiaside I; 2. Forsythiaside A; 3. (+) pinoresin-β-D-pyranoglucoside; 4. Forsythiaside; 5. Forsythiaside.

[0022] Figure 8 The HPLC diagram of the reference substance mixed solution I at different detection wavelengths in Comparative Example 7 of the present invention; in the diagram, 1, forsythiaside I; 2, forsythiaside A; 3, (+) pinoresin-β-D-pyranoglucoside; 4, forsythiaside; 5, forsythiaside. DETAILED DESCRIPTION

[0023] In order to facilitate the understanding of the present invention, the present invention will be described more fully below. The present invention can be implemented in many different forms and is not limited to the embodiments described herein. On the contrary, the purpose of providing these embodiments is to make the understanding of the disclosure of the present invention more thorough and comprehensive.

[0024] Unless otherwise defined, all technical and scientific terms used in the present invention have the same meaning as those commonly understood by those skilled in the art to which the present invention belongs. The terms used in the specification of the present invention are only for the purpose of describing specific embodiments and are not intended to limit the present invention. The term "and / or" used in the present invention includes any and all combinations of one or more of the related listed items.

[0025] The experimental methods in the following examples without specifying specific conditions are usually carried out under conventional conditions or conditions recommended by the manufacturers. The various commonly used chemical reagents used in the examples are all commercially available products.

[0026] In the present invention, in view of the deficiency of the existing Toujie Quwen preparation that only determines the content of a single component, the preparation method of the test solution is continuously explored (so that the five components to be tested in the Toujie Quwen preparation are fully extracted, ensuring the accuracy of the test results), the liquid chromatography conditions for HPLC detection (because the Toujie Quwen granules are made of 16 medicinal materials with complex ingredients, the liquid chromatography conditions must ensure that Forsythin and the other four components to be tested can stably elute and be well separated, and the relative retention time, relative correction factor and peak shape must be stable to meet the detection requirements of the one-test-multiple-evaluation method), and the screening of internal standard detection substances (Forsythin is a substance with a high content in the Toujie Quwen granules, stable ingredients, good separation, and the peak position is in the middle part of the chromatogram). components, selecting forsythiaside as the internal standard can reduce the error of relative retention time and relative peak area of ​​other chromatographic peaks, and it has the advantages of being cheap and easily available), selection of test substances (forsythiaside I, forsythiaside A, (+) pinoresinol-β-D-pyranoglucoside, forsythiaside) and establishing stable relative correction factors between the internal standard test substance and other test substances. Under the joint action of these key parameters, a one-measurement-multiple-evaluation method for determining the contents of five components in the Toujie Quwen preparation was established, that is, only a single reference substance was used to detect the internal standard to determine the content of forsythiaside, and the relative correction factors could be used to calculate the contents of forsythiaside I, forsythiaside A, (+) pinoresinol-β-D-pyranoglucoside, and forsythiaside.

[0027] Compared with the current quality control method of using standard products to detect a single component, the method of the present invention can accurately determine multiple important components of the Toujie Quwen preparation at the same time, more comprehensively reflect the quality of the Toujie Quwen preparation, and provide material basis information for related scientific research. It also solves the problem that the Forsythiaside A reference solution is unstable and needs to be prepared and used immediately, greatly saving the cost of standard products and other test drugs and the detection time.

[0028] In some embodiments of the present invention, a method for determining the contents of five components in a tolujiequwen preparation is disclosed, wherein the five components are forsythiaside, forsythiaside I, forsythiaside A, (+) pinoresinol-β-D-pyranoglucoside and forsythiaside, comprising the following steps:

[0029] (1) Using 50% to 70% methanol as the extraction solvent, ultrasonically extract the test permeable and anti-plaque preparation, filter, and take the filtrate to obtain the test sample solution;

[0030] (2) HPLC detection was performed on the forsythiaside reference solution with a series of concentrations and the test solution of step (1) to obtain a chromatogram; in the HPLC detection, the mobile phase A was acetonitrile, the mobile phase B was 0.1%~1% phosphoric acid aqueous solution, and the gradient elution program was: 0min→30min, 14%~15%A; 30min→31min, 14%~15%→23%~24%A, 31min→50min, 23%~24%A; 50min→65min, 23%~24%→60%A;

[0031] (3) calculating the content of forsythiaside in the to-be-tested tolujiequwen preparation according to the peak area of ​​forsythiaside in the chromatogram of step (2);

[0032] (4) According to the formula (C i / W)×(A r / A i )×V×D×F i / r , calculate the contents of forsythiaside I, forsythiaside A, (+) pinoresinol-β-D-pyranoglucoside and forsythiaside in the tested toluene-resolving and anti-epidemic preparation; where C i is the concentration of forsythin in the tested peony root preparation, W is the sampling amount of the tested peony root preparation, A r is the peak area of ​​forsythiaside I, forsythiaside A, (+) pinoresinol-β-D-pyranoglucopyranoside, or forsythiaside. i is the peak area of ​​forsythiaside, V is the volume of the extraction solvent, D is the dilution factor, F i / r is the relative correction factor of forsythiaside I, forsythiaside A, (+) pinoresinol-β-D-pyranoglucoside, or forsythiaside; the relative correction factors of forsythiaside I, forsythiaside A, (+) pinoresinol-β-D-pyranoglucoside, or forsythiaside are 2.21±0.30, 2.21±0.30, 1.20±0.30, and 0.71±0.30, respectively.

[0033] In some embodiments, the gradient elution program in step (2) is: 0 min→30 min, 14% A; 30 min→31 min, 14%→23% A, 31 min→50 min, 23% A; 50 min→65 min, 23%→60% A.

[0034] In some embodiments, the relative correction factors of forsythiaside I, forsythiaside A, (+) pinoresinol-β-D-pyranoglucopyranoside, or forsythiaside are 2.21±0.15, 2.21±0.5, 1.20±0.15, and 0.71±0.15, respectively.

[0035] In some embodiments, in the HPLC detection in step (2), the chromatographic column used is a C18 chromatographic column.

[0036] In some embodiments, the conditions of the HPLC detection in step (2) also include: flow rate: 0.8 mL / min~1.2 mL / min (preferably 1.0 mL / min); detection wavelength: 210 nm~260 nm (preferably 235 nm); column temperature: 20°C~30°C (preferably 25°C); injection volume: 5 μL~20 μL (preferably 10 μL).

[0037] In some embodiments, the concentration of methanol in step (1) is 65% to 70%.

[0038] In some of the embodiments, the volume of the extraction solvent in step (1) is 20 mL / g to 50 mL / g of the tested permeabilization and anti-epidemic preparation, preferably 20 mL / g to 30 mL / g of the tested permeabilization and anti-epidemic preparation, and more preferably 25 mL / g of the tested permeabilization and anti-epidemic preparation.

[0039] In some embodiments, the ultrasonic power of the ultrasonic extraction in step (1) is 150 W to 250 W, the ultrasonic frequency is 75 kHz to 85 kHz, and the ultrasonic time is 15 min to 45 min.

[0040] In some embodiments, a method for determining the contents of five components in a permeable and anti-plague preparation comprises the following steps:

[0041] (1) Grind the to-be-tested permeable and anti-epidemic preparation into powder, accurately weigh 1 g, accurately add 20 mL to 30 mL of 65% to 70% methanol solution, weigh the weight, ultrasonicate for 15 min to 45 min, let cool, weigh the weight again, make up the lost weight with 65% to 70% methanol, shake well, filter, and take the filtrate, which is the test solution; weigh the forsythiaside reference substance, dissolve and dilute it with methanol to obtain a series of forsythiaside reference substance solutions;

[0042] (2) The test solution of step (1) and the forsythiaside reference solution of a series of concentrations are respectively subjected to HPLC detection to obtain a chromatogram; in the HPLC detection, the mobile phase A is acetonitrile, the mobile phase B is a 0.15% to 0.25% phosphoric acid aqueous solution, and the gradient elution program is: 0 min→30 min, 14%A; 30 min→31 min, 14%→23%A, 31 min→50 min, 23%A; 50 min→65 min, 23%→60%A;

[0043] (3) calculating the content of forsythiaside in the to-be-tested tolujiequwen preparation according to the peak area of ​​forsythiaside in the chromatogram of step (2);

[0044] (4) According to the formula (C i / W)×(A r / A i )×V×D×F i / r , calculate the contents of forsythiaside I, forsythiaside A, (+) pinoresinol-β-D-pyranoglucoside and forsythiaside in the tested permeable and anti-epidemic preparation; the relative correction factors of the forsythiaside I, forsythiaside A, (+) pinoresinol-β-D-pyranoglucoside or forsythiaside are 2.21±0.15, 2.21±0.5, 1.20±0.15 and 0.71±0.15, respectively.

[0045] In other embodiments of the present invention, disclosed is the application of the method for determining the contents of the five components in the above-mentioned Toujie Qubing preparation in the quality control of the Toujie Qubing preparation.

[0046] In the following examples, the instruments used include: Agilent 1260 high performance liquid chromatograph; Waters 2695 high performance liquid chromatograph; Elite Hypersil ODS2 (250 mm×4.6 mm, 5 μm); Agilent ZORBAX SB-C18 (250 mm×4.6 mm, 5 μm); Waters Xbridge (250 mm×4.6 mm, 5 μm); CP225D one-hundred-thousandth balance (German Sartorius); BT 214D one-thousandth balance (German Sartorius); GenieU 12 ultrapure water instrument (Shanghai Lefeng Biotechnology Co., Ltd.). The materials used include: 9 batches of Toujie Qunwen Granules samples came from Guangzhou Baiyunshan Hutchison Whampoa Chinese Medicine Co., Ltd., with batch numbers: A23A001, A23A002, A23A003, L22A001, L22A002, K22A002, 20220204, 20220205, and 20220206; 3 batches of Toujie Qunwen Granules samples came from Guangdong Yifang Pharmaceutical Co., Ltd. (produced under the commission of Guangzhou Eighth People's Hospital), with batch numbers: J2108015, J2108016, and J2108017. The reference substances forsythiaside A (batch number: 111810-202108, purity: 96.2%) and forsythiaside (batch number: 110821-202117, purity: 94.9%) were purchased from China Food and Drug Inspection Institutes; the reference substances forsythiaside I (batch number: ST20200120-14297, purity: 99.3%), (+) pinoresinol-β-D-pyranoglucopyranoside (batch number: ST15550120-14296, purity 99.3%), and forsythiaside (batch number: ST21060120-12632, purity: 98.8%) were purchased from Shanghai Stand Biotechnology Co., Ltd.; acetonitrile was chromatographically pure (Merck, Germany); phosphoric acid was chromatographically pure (Kermiou); and methanol was analytically pure (Guangzhou Chemical Reagent Factory).

[0047] The present invention is described in detail below with reference to the accompanying drawings and specific embodiments.

[0048] Example 1 Method for detecting the contents of five components in the tolujiequwen preparation

[0049] The following steps are involved:

[0050] 1. Prepare the test solution

[0051] Take the Toujie Quwen granules to be tested (batch number: 20220205), grind them into powder, accurately weigh 1 g, accurately add 25 mL of 70% methanol, weigh the weight, ultrasonically treat (power 200 W, frequency 80 kHz) for 30 min, cool, weigh the weight again, make up the lost weight with methanol, shake well, filter, and take the filtrate to obtain the test solution.

[0052] 2. Preparation of Forsythiaside Reference Solution

[0053] Take an appropriate amount of Forsythiaside reference substance, weigh it accurately, add methanol to make a mother solution containing 0.2 mg per mL, and then make a gradient Forsythiaside reference substance solution.

[0054] 3. HPLC detection

[0055] The test solution and the forsythiaside reference solution were tested by HPLC, and the chromatographic conditions were as follows:

[0056] Chromatographic column: Elite Hypersil ODS2 (250 mm × 4.6 mm, 5 μm);

[0057] Mobile phase: acetonitrile (A)-0.2% phosphoric acid aqueous solution (B);

[0058] Gradient elution: 0min~30min, 14%A; 30min~31min, 14%→23%A, 31min~50min, 23%A; 50min~65min, 23%→60%A;

[0059] Flow rate: 1.0 mL / min;

[0060] Detection wavelength: 235nm;

[0061] Column temperature: 25°C;

[0062] Injection volume: 10 μL.

[0063] 4. Experimental results

[0064] ①HPLC chart of Toujie Quwen granules Figure 1 As shown. Figure 1 It can be seen that, using the detection conditions of this embodiment, the characteristic peaks of the five components forsythiaside I, forsythiaside A, (+) pinoresinol-β-D-pyranoglucoside, forsythiaside and forsythiaside are well separated, the peaks emerge quickly and the baseline is stable.

[0065] ② Determination of the content of forsythiaside

[0066] According to the peak area of ​​forsythiaside in the test solution, the external standard method was used and the forsythiaside content = C i×V×D / W, the content of forsythin in the tested Toujie Quwen granules sample was calculated to be 1.5360 mg / g. i is the concentration of forsythiaside (mg / mL), V is the volume of the extraction solvent (mL, in this embodiment, 25 mL), W is the sampling amount of the Toujie Quwen granules sample (g, in this embodiment, about 1 g), and D is the dilution factor (in this embodiment, 1).

[0067] ③Relative correction factor F i / r The calculation formula is as follows: i / r =F i / F r =(A i × C r ) / (A r × C i ), where A i is the peak area of ​​forsythiaside; A r is the peak area of ​​the component to be tested; C i is the concentration of forsythiaside; C r In this embodiment, the relative correction factors of forsythiaside I, forsythiaside A, (+) pinoresinol-β-D-pyranoglucoside, and forsythiaside are 2.21, 2.21, 1.20, and 0.71, respectively.

[0068] ④According to the formula content (mg / g) = (C i / W)×(A r / A i )×V×D×F i / r , calculate the contents of forsythiaside I, forsythiaside A, (+) pinoresinol-β-D-pyranoglucoside and forsythiaside in the test solution, where C i is the concentration of forsythin (mg / mL), W is the sampling amount of the Toujie Quwen granules (g, in this embodiment, about 1g), A r A is the peak area of ​​the component to be tested in the test solution. i is the peak area of ​​forsythiaside in the test solution, V is the volume of the extraction solvent (mL, in this embodiment, 25 mL), D is the dilution factor (in this embodiment, 1), F i / r is the relative correction factor.

[0069] After calculation, the contents of forsythiaside I, forsythiaside A, (+) pinoresinol-β-D-pyranoglucoside and forsythiaside in the tested Toujiequwen granules of this example are 4.1829, 9.6794, 1.3423 and 0.0851 mg / g, respectively.

[0070] Example 2 Methodological Study of the Detection Method of the Present Invention

[0071] 1. Linear relationship investigation

[0072] Accurately weigh appropriate amounts of five reference substances and use methanol to prepare reference substance mixed solution mother solutions (reference substance mixed solution I) with concentrations of 0.3495 mg / mL, 0.7869 mg / mL, 0.1195 mg / mL, 0.1219 mg / mL, and 6.804 μg / mL forsythiaside I, 0.7869 mg / mL, 0.1195 mg / mL, 0.1219 mg / mL, and 6.804 μg / mL, respectively.

[0073] Accurately measure 10 mL of reference substance mixture I, place it in a 20 mL volumetric flask, add methanol to dilute to the scale, shake well, and obtain reference substance mixture II; accurately measure 1 mL of reference substance mixture II, place it in a 10 mL volumetric flask, add methanol to dilute to the scale, shake well, and obtain reference substance mixture III; accurately measure 2 mL of reference substance mixture II, place it in a 10 mL volumetric flask, add methanol to dilute to the scale, shake well, and obtain reference substance mixture IV; accurately measure 5 mL of reference substance mixture II, place it in a 10 mL volumetric flask, add methanol to dilute to the scale, shake well, and obtain reference substance mixture V; accurately measure 1.5 mL of reference substance mixture I, place it in a 2 mL volumetric flask, add methanol to dilute to the scale, shake well, and obtain reference substance mixture VI.

[0074] The reference substance mixtures I to VI were measured according to the chromatographic conditions in Example 1. The HPLC chart of the reference substance mixture I is as follows: Figure 2 The peak area Y is used as the ordinate and the injection volume (μg) X is used as the abscissa for regression analysis.

[0075] The results are shown in Table 1.

[0076] Table 1 Regression equations and linear ranges of the five components

[0077]

[0078] The results in Table 1 show that all the tested components showed good linear relationships.

[0079] 2. Precision test

[0080] Accurately pipette 10 μL of reference substance mixed solution II, and continuously inject 6 times according to the chromatographic conditions in Example 1, record the peak areas of forsythiaside I, forsythiaside A, (+) pinoresinol-β-D-pyranoglucoside, forsythiaside, and forsythiaside, and calculate the RSD.

[0081] The RSDs (n=5) of the peak areas of the components were 0.63%, 0.69%, 0.57%, 0.53%, and 0.67%, respectively, indicating that the instrument had good precision.

[0082] 3. Stability test

[0083] The same batch of Toujie Quwen granules (batch number: 20220205) was used to prepare the test solution. The samples were injected and analyzed at 0, 2, 4, 6, 8, 12, 24, and 48 h according to the chromatographic conditions in Example 1, and the peak areas of forsythiaside I, forsythiaside A, (+) pinoresin-β-D-pyranoglucoside, forsythiaside, and forsythiaside were recorded, and the RSD was calculated.

[0084] The RSDs of the peak areas of the components (n=5) were 3.11%, 1.30%, 3.57%, 2.71% and 0.87%, respectively. The results showed that the test solution was stable within 48 hours.

[0085] 4. Repeatability test

[0086] Six test solutions were prepared from the same batch of Toujie Quwen Granules (Batch No.: 20220205), and the samples were injected and analyzed according to the chromatographic conditions in Example 1 to determine the average contents of forsythiaside I, forsythiaside A, (+) pinoresinol-β-D-pyranoglucoside, forsythiaside, and forsythiaside in the six test solutions.

[0087] The results showed that the average contents of forsythiaside I, forsythiaside A, (+) pinoresinol-β-D-pyranoglucoside, forsythiaside and forsythiaside in the six test solutions were 4.3204 mg / mL, 9.3503 mg / mL, 1.3772 mg / mL, 1.5203 ​​mg / mL and 0.08351 mg / mL, with RSDs of 2.19%, 1.29%, 2.96%, 1.77% and 0.86%, respectively. The results showed that the method had good repeatability.

[0088] 5. Sample recovery test

[0089] Take 9 portions of the same batch of Toujie Quwen Granules (Batch No.: 20220205), 0.5 g per portion, accurately weighed, and divided into three parallel groups, 3 portions in each group, and add forsythiaside I, forsythiaside A, (+) pinoresin-β-D-pyranoglucoside, forsythiaside, and forsythiaside reference substances at a ratio of 1:0.5, 1:1, and 1:1.5, respectively. Prepare the test solution according to the method of Example 1, and measure the sample according to the chromatographic conditions of Example 1, record the peak area and calculate the sample recovery rate. The results are shown in Table 2.

[0090] Table 2 Results of sample recovery test (n=9)

[0091] ;

[0092]

[0093] The results in Table 2 show that the recoveries of the five chemical components were all within 85% to 110%, indicating that the method had good accuracy.

[0094] 6. Durability evaluation

[0095] Accurately draw the reference substance mixture I to VI, inject and analyze according to the chromatographic conditions in Example 1, and record the peak areas of forsythiaside I, forsythiaside A, (+) pinoresinol-β-D-pyranoglucoside, forsythiaside, and forsythiaside. Take forsythiaside as the internal standard, according to the formula ( f ) = ( A i × C r ) / ( A r × C i )(in, A i is the peak area of ​​the internal standard; A r is the peak area of ​​the component to be tested; C i is the concentration of the internal standard; C r is the concentration of the component to be tested), the relative positive factors of forsythiaside I, forsythiaside A, (+) pinoresinol-β-D-pyranoglucoside and forsythiaside at different concentrations were calculated. The results are shown in Table 3.

[0096] Table 3 Determination results of relative correction factors of five components in Toujie Quwen granules

[0097]

[0098] The results in Table 3 show that the relative correction factors of the five components of the reference substance are stable at different concentrations, with no significant differences.

[0099] The relative correction factors of forsythiaside I, forsythiaside A, (+) pinoresinol-β-D-pyranoglucoside and forsythiaside using three different brands of chromatographic columns, namely Elite Hypersil ODS2, Agilent ZORBAX SB-C18 and Waters Xbridge, on Waters e2695 and Agilent 1260 were investigated respectively. The results are shown in Table 4.

[0100] Table 4 Effects of different instruments and columns on the relative correction factors of each component

[0101]

[0102] The results in Table 4 show that the RSDs of the relative correction factors of each component are all <5%, indicating that different instruments and different chromatographic columns have no significant effect on the relative correction factors of each component.

[0103] 7. Positioning of chromatographic peaks of components to be measured

[0104] The reference substance mixture I was accurately aspirated, and the relative retention values ​​of the tested components, forsythiaside I, forsythiaside A, (+) pinoresinol-β-D-pyranoglucoside, and forsythiaside were determined and calculated using three different brands of chromatographic columns, namely, Elite Hypersil ODS2, Agilent ZORBAX SB-C18, and Waters Xbridge, in two instruments, Waters e2695 and Agilent 1260. The results are shown in Table 5.

[0105] Table 5 Relative retention time results of different instruments and different chromatographic columns

[0106]

[0107] The results in Table 5 show that different brands of chromatographs and different brands of chromatographic columns have little effect on relative retention time (RSD < 4%). Therefore, the chromatographic peaks of each component can be located according to the relative retention value method.

[0108] 8. Comparison with the results of external standard method

[0109] 10 μL of the test solution of 11 batches of Toujie Quwen Granules was taken for sample analysis. The detection method (QAMS) of Example 1 and the external standard method (ESM) were used to calculate the contents of forsythiaside I, forsythiaside A, (+) pinoresinol-β-D-pyranoglucoside and forsythiaside. The results are shown in Table 6.

[0110] Table 6 Determination results of five components in Toujiequbing by different methods (mg / g)

[0111]

[0112] The results in Table 6 show that there is no significant difference in the contents obtained by the two methods (RAD < 4%), indicating that the method of the present invention can be used to determine the contents of the five components in Toujie Quwen granules.

[0113] Comparative Example 1

[0114] This comparative example provides a method for detecting a penetrating and anti-plague preparation, comprising the following steps:

[0115] 1. Prepare the test solution

[0116] Same as Example 1

[0117] 2. HPLC detection

[0118] Except that the gradient elution program was: 0 min-40 min, 15% A, 40 min-70 min, 15%-55% A, other chromatographic conditions were the same as in Example 1.

[0119] 3. Experimental results

[0120] Using the chromatographic conditions of this comparative example, the HPLC chart of Toujie Quwen granules is as follows: Figure 3 As shown. Figure 3 It can be seen that under the chromatographic conditions of this comparative example, the target components are concentrated in the 50-60 minute time period, which makes it difficult to separate some target component peaks, among which forsythin and forsythiaside have very poor separation. Therefore, the detection method of this comparative example cannot determine the content of forsythin, and it is even more impossible to calculate the contents of the other four components based on the content of forsythin.

[0121] Comparative Example 2

[0122] This comparative example provides a method for detecting a penetrating and anti-plague preparation, comprising the following steps:

[0123] 1. Prepare the test solution

[0124] Same as Example 1

[0125] 2. HPLC detection

[0126] Except that the gradient elution program was: 0 min-30 min, 15% A, 30 min-35 min, 15%-30% A, 35 min-70 min, 30%-35% A, other chromatographic conditions were the same as those in Example 1.

[0127] 3. Experimental results

[0128] Using the chromatographic conditions of this comparative example, the HPLC chart of Toujie Quwen granules is as follows: Figure 4 As shown. Figure 4 It can be seen that under the chromatographic conditions of this comparative example, the target components are concentrated in the 35-45 minute period, which makes it difficult to separate some target component peaks, and the separation of forsythiaside and forsythiaside is very poor. Therefore, the detection method of this comparative example cannot determine the content of forsythiaside, nor can the contents of the other four components be calculated based on the content of forsythiaside.

[0129] Comparative Example 3

[0130] This comparative example provides a method for detecting a penetrating and anti-plague preparation, comprising the following steps:

[0131] 1. Prepare the test solution

[0132] Same as Example 1

[0133] 2. HPLC detection

[0134] Except that the gradient elution program was: 0 min-30 min, 15% A, 30 min-35 min, 15%-20% A, 35 min-70 min, 20%-30% A, other chromatographic conditions were the same as those in Example 1.

[0135] 3. Experimental results

[0136] Using the chromatographic conditions of this comparative example, the HPLC chart of Toujie Quwen granules is as follows: Figure 5 As shown. Figure 5 It can be seen that under the chromatographic conditions of this comparative example, no forsythiaside chromatographic peak appears, so the detection method of this comparative example cannot simultaneously determine the content of forsythiaside. In addition, there is basically no peak in the 30min~50min period, which wastes detection time.

[0137] Comparative Example 4

[0138] This comparative example provides a method for detecting a penetrating and anti-plague preparation, comprising the following steps:

[0139] 1. Prepare the test solution

[0140] Same as Example 1

[0141] 2. HPLC detection

[0142] Except that the gradient elution program was: 0 min~30 min, 15% A, 30 min~31 min, 15%~20% A, 31 min~50 min, 20%~25% A, 50 min~60 min, 25%~55% A, other chromatographic conditions were the same as those in Example 1.

[0143] 3. Experimental results

[0144] Using the chromatographic conditions of this comparative example, the HPLC chart of Toujie Quwen granules is as follows: Figure 6 As shown. Figure 6 It can be seen that under the chromatographic conditions of this comparative example, there is basically no peak in the 30-45 minute period, which wastes time. At the same time, forsythin is inseparable from the previous miscellaneous peaks, and the separation degree does not meet the requirements for content determination. Therefore, the detection method of this comparative example cannot determine the content of forsythin, nor can the contents of the other four components be calculated based on the content of forsythin.

[0145] Comparative Example 5

[0146] This comparative example provides a method for detecting a penetrating and anti-plague preparation, comprising the following steps:

[0147] 1. Prepare the test solution

[0148] Same as Example 1

[0149] 2. HPLC detection

[0150] Except that the gradient elution program was: 0 min~30 min, 15% A, 30 min~31 min, 15%~24% A, 31 min~50 min, 24% A, 50 min~60 min, 24%~60% A, other chromatographic conditions were the same as in Example 1.

[0151] 3. Experimental results

[0152] Using the chromatographic conditions of this comparative example, the HPLC chart of Toujie Quwen granules is as follows: Figure 7 As shown. Figure 7 It can be seen that under the chromatographic conditions of this comparative example, each chromatographic peak emerges late, and the peak width is pulled wider, resulting in poor separation between forsythiaside and the small peak in front, and it is impossible to accurately quantify, and the last peak of forsythiaside emerges after about 60 minutes, which prolongs the detection time and increases the quality control cost. Therefore, the detection method of this comparative example cannot accurately determine the content of forsythiaside, and it is even more impossible to calculate the contents of the other four components based on the content of forsythiaside.

[0153] Comparative Example 6 Selection of internal reference in the detection method of the present invention

[0154] In this comparative example, forsythiaside I was selected as the internal reference. According to the method of Example 1, three different brands of chromatographic columns, namely, Hypersil ODS2, Agilent ZORBAX SB-C18 and WatersXbridge, were used in two instruments, Waters e2695 and Agilent 1260, to respectively determine the relative retention times of the components to be tested, forsythiaside A, (+) pinoresinol-β-D-pyranoglucopyranoside and forsythiaside. The relative retention time results of different instruments and different chromatographic columns are shown in Table 7.

[0155] Table 7 Relative retention time results of different instruments and different chromatographic columns

[0156]

[0157] The results in Table 7 show that the peak time of Forsythiaside I is relatively early, which makes it easy to produce errors in the relative retention time when calculating the content of other substances (RSD>5%). Therefore, Forsythiaside I is not suitable as an internal reference substance in the detection method of the present invention.

[0158] Comparative Example 7 Effect of the Preparation Method of the Test Solution on the Extraction Rates of the Five Components to be Tested

[0159] 1. Extraction solvent

[0160] In this comparative example, the test solution was prepared using the method of Example 1, except that 50% methanol, 70% methanol, methanol, and 70% ethanol were used as extraction solvents. The extraction rates of the five components by different extraction solvents are shown in Table 8.

[0161] Table 8 Extraction rate results of different extraction solvents

[0162]

[0163] The results in Table 8 show that the extraction rates of the five components by 50% to 70% methanol are good, and the extraction rate is the best when 70% methanol is used as the extraction solvent; while the extraction effects of 70% ethanol solution and pure methanol are not ideal.

[0164] 2. Volume of extraction solvent

[0165] 10 mL, 25 mL, and 50 mL of 70% methanol were used as extraction reagents to prepare the test solution, and the other steps were the same as in Example 1. The extraction rates of the five components with different volumes of extraction solvents are shown in Table 9.

[0166] Table 9 Extraction rate results of different extraction volumes

[0167]

[0168] The results in Table 9 show that when the extraction volume is 25 mL and 50 mL, the extraction rates of the five components are similar and better than the extraction effect of 10 mL. In order to save solvent, 25 mL of 70% methanol was selected as the extraction reagent.

[0169] 3. Extraction method

[0170] The test solution was prepared by cold soaking overnight, ultrasonication for 5 min, ultrasonication for 15 min, ultrasonication for 30 min, and heating under reflux for 1 h, respectively, and the other steps were the same as those in Example 1. The extraction rates of the five components by different extraction methods are shown in Table 10.

[0171] Table 10 Extraction rate results of different extraction methods

[0172]

[0173] Combined with the results in Table 10, and considering the extraction time, efficiency and stability, the extraction effect was best when ultrasonic extraction was performed for 30 min.

[0174] In summary, in the detection method of the present invention, the optimal method for preparing the test solution is: grind the Toujie Quwen granules, accurately weigh 1 g, accurately add 25 mL of 70% methanol, weigh the weight, ultrasonically treat (power 200 W, frequency 80 kHz) for 30 minutes, cool, weigh again, make up the lost weight with 70% methanol, shake well, filter, and take the filtrate to obtain.

[0175] Comparative Example 8 Effect of Detection Wavelength on Detection Results in HPLC Conditions

[0176] According to the UV spectra of the five chemical components and the detection wavelength in the [Content Determination] under the item of Forsythia suspensa in the Chinese Pharmacopoeia (2020 Edition), the chromatograms of the test solution (same as in Example 1) were investigated at 235 nm, 270 nm, and 330 nm (other conditions were the same as in Example 1), and the results were as follows: Figure 8 shown.

[0177] from Figure 8 It can be seen that when the detection wavelength is 235 nm, the chromatographic peak areas of the five chemical components are the largest, which can be used as the detection wavelength for determining the content of multiple components of Toujie Quwen granules in the present invention. When the detection wavelength is 270 nm and 330 nm, the peaks of components such as forsythiaside A and forsythiaside are very small or do not appear, and cannot be detected.

[0178] The above-mentioned embodiments only express several implementation methods of the present invention, and the descriptions thereof are relatively specific and detailed, but they cannot be understood as limiting the scope of the invention patent. It should be pointed out that, for ordinary technicians in this field, several variations and improvements can be made without departing from the concept of the present invention, and these all belong to the protection scope of the present invention. Therefore, the protection scope of the patent of the present invention shall be subject to the attached claims.

Claims

1. A method for determining the contents of five components in a tolujiequwen preparation, characterized in that: The five components are forsythiaside, forsythiaside I, forsythiaside A, (+) pinoresinol-β-D-pyranoglucoside and forsythiaside, comprising the following steps: (1) Using 50% to 70% methanol as the extraction solvent, ultrasonically extract the test permeable and anti-plague preparation, filter, and take the filtrate to obtain the test sample solution; (2) performing HPLC detection on the forsythiaside reference solution with a series of concentrations and the test solution of step (1) to obtain a chromatogram; in the HPLC detection, the chromatographic column used is a C18 chromatographic column; Mobile phase A was acetonitrile, mobile phase B was 0.1%~1% phosphoric acid aqueous solution, and the gradient elution program was: 0min→30min, 14%~15% mobile phase A; 30min→31min, 14%~15% mobile phase A→23%~24% mobile phase A, 31min→50min, 23%~24% mobile phase A; 50min→65min, 23%~24% mobile phase A→60% mobile phase A; (3) calculating the content of forsythiaside in the to-be-tested tolujiequwen preparation according to the peak area of ​​forsythiaside in the chromatogram of step (2); (4) According to the formula (C i / W)×(A r / A i )×V×D×F i / r , calculate the contents of forsythiaside I, forsythiaside A, (+) pinoresinol-β-D-pyranoglucoside and forsythiaside in the tested toluene-resolving and anti-epidemic preparation; where C i is the concentration of forsythin in the tested peony root preparation, W is the sampling amount of the tested peony root preparation, A r is the peak area of ​​forsythiaside I, forsythiaside A, (+) pinoresinol-β-D-pyranoglucopyranoside, or forsythiaside. i is the peak area of ​​forsythiaside, V is the volume of the extraction solvent, D is the dilution factor, F i / r is the relative correction factor of forsythiaside I, forsythiaside A, (+) pinoresinol-β-D-pyranoglucoside, or forsythiaside; the relative correction factors of forsythiaside I, forsythiaside A, (+) pinoresinol-β-D-pyranoglucoside, or forsythiaside are 2.21±0.30, 2.21±0.30, 1.20±0.30, and 0.71±0.30, respectively.

2. The method for determining the contents of five components in the tolujiequwen preparation according to claim 1, characterized in that: The gradient elution program in step (2) is: 0 min→30 min, 14% mobile phase A; 30 min→31 min, 14% mobile phase A→23% mobile phase A, 31 min→50 min, 23% mobile phase A; 50 min→65 min, 23% mobile phase A→60% mobile phase A.

3. The method for determining the contents of five components in the permeable and anti-plague preparation according to claim 1, characterized in that: The relative correction factors of the forsythiaside I, forsythiaside A, (+) pinoresinol-β-D-pyranoglucoside, or forsythiaside are 2.21±0.15, 2.21±0.5, 1.20±0.15, and 0.71±0.15, respectively.

4. The method for determining the contents of five components in the tolujiequwen preparation according to any one of claims 1 to 3, characterized in that: The conditions for the HPLC detection in step (2) also include: flow rate: 0.8 mL / min~1.2 mL / min; detection wavelength: 210 nm~260 nm; column temperature: 20°C~30°C; injection volume: 5 μL~20 μL.

5. The method for determining the contents of five components in the permeable and anti-plague preparation according to any one of claims 1 to 3, characterized in that: The concentration of methanol in step (1) is 65% to 70%.

6. The method for determining the contents of five components in the tolujiequwen preparation according to any one of claims 1 to 3, characterized in that: The volume of the extraction solvent in step (1) is 20 mL / g~50 mL / g of the tested anti-epidemic preparation, and / or the ultrasonic power of the ultrasonic extraction in step (1) is 150 W~250 W, the ultrasonic frequency is 75 kHz~85 kHz, and the ultrasonic time is 15 min~45 min.

7. The method for determining the contents of five components in the permeable and anti-plague preparation according to claim 6, characterized in that: The volume of the extraction solvent in step (1) is 20 mL / g~30 mL / g of the tested anti-epidemic preparation, and / or the ultrasonic extraction time in step (1) is 25 min~35 min.

8. The method for determining the contents of five components in the tolujiequwen preparation according to claim 1, characterized in that: The following steps are involved: (a) Grind the to-be-tested peony-clearing preparation into powder, accurately weigh 1 g, accurately add 20 mL to 30 mL of 65% to 70% methanol solution, weigh the weight, ultrasonicate for 15 min to 45 min, cool, weigh again, make up the lost weight with 65% to 70% methanol, shake well, filter, and take the filtrate to obtain the test solution; weigh the forsythiaside reference substance, dissolve and dilute it with methanol to obtain a series of forsythiaside reference substance solutions; (b) performing HPLC detection on the test solution of step (a) and the forsythiaside reference solution of a series of concentrations to obtain a chromatogram; in the HPLC detection, the mobile phase A is acetonitrile, the mobile phase B is 0.15% to 0.25% phosphoric acid aqueous solution, and the gradient elution program is: 0 min → 30 min, 14% mobile phase A; 30 min → 31 min, 14% mobile phase A → 23% mobile phase A, 31 min → 50 min, 23% mobile phase A; 50 min → 65 min, 23% mobile phase A → 60% mobile phase A; (c) calculating the content of forsythiaside in the to-be-tested tolujiequwen preparation according to the peak area of ​​forsythiaside in the chromatogram of step (b); (d) According to the formula (C i / W)×(A r / A i )×V×D×F i / r , calculate the contents of forsythiaside I, forsythiaside A, (+) pinoresinol-β-D-pyranoglucoside and forsythiaside in the tested permeable and anti-epidemic preparation; the relative correction factors of the forsythiaside I, forsythiaside A, (+) pinoresinol-β-D-pyranoglucoside or forsythiaside are 2.21±0.15, 2.21±0.5, 1.20±0.15 and 0.71±0.15, respectively.

9. Application of the method for determining the contents of five components in the Toujie Qubing preparation according to any one of claims 1 to 8 in the quality control of the Toujie Qubing preparation.